(Q35162676)

6 August 2017

1 reference

title

The burden of uncontrolled hypertension: morbidity and mortality associated with disease progression (English)

1 reference

6 August 2017

1 reference

William C Cushman

1

1 reference

6 August 2017

language of work or name

1 reference

1 May 2003

1 reference

Journal of Clinical Hypertension

6 August 2017

published in

1 reference

6 August 2017

volume

5

1 reference

6 August 2017

issue

3 Suppl 2

1 reference

6 August 2017

page(s)

14-22

1 reference

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Blood pressure, systolic and diastolic, and cardiovascular risks. US population data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Differential impact of systolic and diastolic blood pressure level on JNC-VI staging. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Clinical Advisory Statement. Importance of systolic blood pressure in older Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Baseline Characteristics and Early Blood Pressure Control in the CONVINCE Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Circadian rhythms and clinical medicine with applications to hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Cardiovascular abnormalities in never-treated hypertensives according to nondipper status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Targeting of the renin-angiotensin system by antisense gene therapy: a possible strategy for the long-term control of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Relationships between 24 h blood pressure load and target organ damage in patients with mild-to-moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Hypertension and the prothrombotic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Localization and function of angiotensin AT1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Salt sensitivity of blood pressure in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Association between salt sensitivity and target organ damage in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

NaCl sensitivity of essential hypertensive patients is related to insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Hyperdynamic circulation and the insulin resistance syndrome ("syndrome X")

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Heart rate and cardiovascular mortality: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1524-6175.2003.02464.X

10.1111/J.1524-6175.2003.02464.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference